Anti-Mouse CD18 [Clone M18/2] — Purified in vivo PLATINUM™ Functional Grade
Anti-Mouse CD18 [Clone M18/2] — Purified in vivo PLATINUM™ Functional Grade
Product No.: C2516
- -
- -
Clone M18/2 Target CD18 Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Alternate Names Integrin β2, β2 integrin, ITGB2 Isotype Rat IgG2a κ Applications FC , IHC , IP , WB , Block , Stimulation |
- -
- -
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Rat Recommended Dilution Buffer Immunogen Mouse CTL glycoprotein Product Concentration ≥ 5.0 mg/ml Endotoxin Level <0.5 EU/mg as determined by the LAL method Purity ≥98% monomer by analytical SEC ⋅ >95% by SDS Page Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. State of Matter Liquid Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Pathogen Testing To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Regulatory Status Research Use Only Country of Origin USA Shipping 2-8° C Wet Ice Applications and Recommended Usage? Quality Tested by Leinco WB Additional Applications Reported In Literature ? Block FC IHC IP Stim Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity M18/2 activity is directed against mouse CD18. Background Integrins are a large family of α/β heterodimeric transmembrane molecules that mediate
adhesion, migration, cell survival, and cell differentiation1. The leukocytic cell-adhesion
molecule (Leu-CAM) family has three members, LFA-1 (CD18/CD11a), CR3 (also known as
MAC-1) (CD18/CD11b), and p150,95 (CD18/CD11c), all of which share the β chain CD182.
Depending on which molecule CD18 is bound to, this β chain plays important roles in
inflammation, initiation of the immune response, phagocytosis, adherence to endothelium,
chemotaxis, and can act as a fibrinogen receptor as part of its heterodimer3. M18/2 was generated by immunizing rat with mouse cytotoxic T cell glycoproteins and fusing the spleen cells with mouse myeloma line P3X63Ag8.6534. M18/2 was selected by immunoprecipitation of LFA-1 and found to bind to the β chain of both LFA-1 and MAC-1. M18/2 has subsequently been used to study lymphoma metastasis3,5, myelin phagocytosis6, platelet caspases and thrombocytosis7, and the immunosuppression of corneal allografts8. Antigen Distribution CD18 is expressed on all leukocytes as well as on myeloid cells. Ligand/Receptor ICAM-1 (CD54), ICAM-2 (CD102), ICAM-3 (CD50), iC3b, fibrinogen NCBI Gene Bank ID UniProt.org Research Area Cell Adhesion . Cell Biology . Immunology . Innate Immunity References & Citations1 Luo BH, Carman CV, Springer TA. Annu Rev Immunol. 25:619-647. 2007. 2 Sanchez-Madrid F, Nagy JA, Robbins E, et al. J Exp Med. 158(6):1785-1803. 1983. 3 Driessens MH, van Hulten P, Zuurbier A, et al. J Leukoc Biol. 60(6):758-765. 1996. 4 Sanchez-Madrid F, Simon P, Thompson S, et al. J Exp Med. 158(2):586-602. 1983. 5 Zahalka MA, Okon E, Naor D. J Immunol. 150(10):4466-4477. 1993. 6 Reichert F, Rotshenker S. Neurobiol Dis. 12(1):65-72. 2003. 7 Piguet PF, Vesin C. Eur J Haematol. 68(5):253-261. 2002. 8 Hori J, Isobe M, Yamagami S, et al. Exp Eye Res. 65(1):89-98. 1997. Technical ProtocolsCertificate of Analysis |
Formats Available
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
